Sigilon Therapeutics Buy Hold or Sell Recommendation
| SGTXDelisted Stock | USD 21.11 0.33 1.54% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Sigilon Therapeutics is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Sigilon Therapeutics given historical horizon and risk tolerance towards Sigilon Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Sigilon Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. In addition, we conduct extensive research on individual companies such as Sigilon and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Sigilon Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Sigilon |
Execute Sigilon Therapeutics Buy or Sell Advice
The Sigilon recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sigilon Therapeutics. Macroaxis does not own or have any residual interests in Sigilon Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sigilon Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Sigilon Therapeutics Trading Alerts and Improvement Suggestions
| Sigilon Therapeutics is not yet fully synchronised with the market data | |
| Sigilon Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.94 M. Net Loss for the year was (43.56 M) with loss before overhead, payroll, taxes, and interest of (24.69 M). | |
| Sigilon Therapeutics currently holds about 88.21 M in cash with (51.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.72. |
Sigilon Therapeutics Returns Distribution Density
The distribution of Sigilon Therapeutics' historical returns is an attempt to chart the uncertainty of Sigilon Therapeutics' future price movements. The chart of the probability distribution of Sigilon Therapeutics daily returns describes the distribution of returns around its average expected value. We use Sigilon Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sigilon Therapeutics returns is essential to provide solid investment advice for Sigilon Therapeutics.
| Mean Return | 6.13 | Value At Risk | -14.07 | Potential Upside | 12.46 | Standard Deviation | 2,111 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sigilon Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Purchase by Eli Lilly Co of 1718493 shares of Sigilon TherapeuticsInc [view details]
Sigilon Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Sigilon . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Sigilon Therapeutics Buy or Sell Advice
When is the right time to buy or sell Sigilon Therapeutics? Buying financial instruments such as Sigilon Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Sigilon Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Technology Thematic Idea Now
Technology
Companies that are involved in development or distribution of technologically based goods and services such as software, IT or electronics. The Technology theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Technology Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Sigilon Stock
If you are still planning to invest in Sigilon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sigilon Therapeutics' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |